Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

ClinicalTrials.gov ID: NCT01196429

Public ClinicalTrials.gov record NCT01196429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 10:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Temsirolimus (CCI-779) (NCI Supplied Agent: NSC# 683864,) in Combination With Carboplatin and Paclitaxel Followed by Temsirolimus Consolidation as First-Line Therapy in the Treatment of Clear Cell Carcinoma of the Ovary

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial studies how well temsirolimus, carboplatin, and paclitaxel as first-line therapy works in treating patients with newly diagnosed stage III-IV clear cell ovarian cancer. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving temsirolimus with combination chemotherapy may be an effective treatment for ovarian cancer.

Study identification

NCT ID
NCT01196429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
Jan 2015 (Actual)
Completion
Jan 2015 (Actual)
Last update posted
Aug 8, 2019

2010 – 2015

United States locations

U.S. sites
121
U.S. states
28
U.S. cities
85
Facility City State ZIP Site status
Saint Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California 91505 —
Los Angeles County-USC Medical Center Los Angeles California 90033 —
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 —
Palo Alto Medical Foundation-Gynecologic Oncology Mountain View California 94040 —
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045 —
Hartford Hospital Hartford Connecticut 06102 —
Saint Francis Hospital and Medical Center Hartford Connecticut 06105 —
The Hospital of Central Connecticut New Britain Connecticut 06050 —
Florida Hospital Orlando Orlando Florida 32803 —
Memorial University Medical Center Savannah Georgia 31404 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 —
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521 —
Good Samaritan Regional Health Center Mount Vernon Illinois 62864 —
Cadence Cancer Center in Warrenville Warrenville Illinois 60555 —
Elkhart Clinic Elkhart Indiana 46514-2098 —
Michiana Hematology Oncology PC-Elkhart Elkhart Indiana 46514 —
Elkhart General Hospital Elkhart Indiana 46515 —
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
Saint Vincent Oncology Center Indianapolis Indiana 46260 —
Community Howard Regional Health Kokomo Indiana 46904 —
IU Health La Porte Hospital La Porte Indiana 46350 —
Michiana Hematology Oncology PC-Mishawaka Mishawaka Indiana 46545 —
Saint Joseph Regional Medical Center-Mishawaka Mishawaka Indiana 46545 —
Michiana Hematology Oncology PC-Plymouth Plymouth Indiana 46563 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
Michiana Hematology Oncology PC-South Bend South Bend Indiana 46601 —
South Bend Clinic South Bend Indiana 46617 —
Northern Indiana Cancer Research Consortium CCOP South Bend Indiana 46628 —
Michiana Hematology Oncology PC-Westville Westville Indiana 46391 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
Iowa Oncology Research Association CCOP Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates-Des Moines Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates-Laurel Des Moines Iowa 50314 —
Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
Iowa Lutheran Hospital Des Moines Iowa 50316 —
University of Kansas Cancer Center Kansas City Kansas 66160 —
Walter Reed Army Medical Center-Olney Olney Maryland 20832 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Lahey Hospital and Medical Center Burlington Massachusetts 01805 —
Baystate Medical Center Springfield Massachusetts 01199 —
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995 —
Michigan Cancer Research Consortium CCOP Ann Arbor Michigan 48106 —
Oakwood Hospital and Medical Center Dearborn Michigan 48124 —
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 —
Saint John Hospital and Medical Center Detroit Michigan 48236 —
Hurley Medical Center Flint Michigan 48502 —
Genesys Regional Medical Center Grand Blanc Michigan 48439 —
Gynecologic Oncology of West Michigan PLLC Grand Rapids Michigan 49546 —
Allegiance Health Jackson Michigan 49201 —
Borgess Medical Center Kalamazoo Michigan 49001 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Sparrow Hospital Lansing Michigan 48912 —
Saint Mary Mercy Hospital Livonia Michigan 48154 —
Michiana Hematology Oncology PC-Niles Niles Michigan 49120 —
Saint Joseph Mercy Oakland Pontiac Michigan 48341 —
Saint Joseph Mercy Port Huron Port Huron Michigan 48060 —
Saint Mary's of Michigan Saginaw Michigan 48601 —
Lakeland Hospital Saint Joseph Michigan 49085 —
Marie Yeager Cancer Center Saint Joseph Michigan 49085 —
Saint John Macomb-Oakland Hospital Warren Michigan 48093 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Mercy Hospital-Joplin Joplin Missouri 64804 —
Cancer Research for the Ozarks NCORP Springfield Missouri 65804 —
Mercy Hospital Springfield Springfield Missouri 65804 —
CoxHealth South Hospital Springfield Missouri 65807 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Cooper Hospital University Medical Center Camden New Jersey 08103 —
Winthrop University Hospital Mineola New York 11501 —
Stony Brook University Medical Center Stony Brook New York 11794 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27710 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Summa Akron City Hospital/Cooper Cancer Center Akron Ohio 44304 —
University of Cincinnati Cincinnati Ohio 45267 —
Case Western Reserve University Cleveland Ohio 44106 —
MetroHealth Medical Center Cleveland Ohio 44109 —
Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 —
Kettering Medical Center Kettering Ohio 45429 —
Hillcrest Hospital Cancer Center Mayfield Heights Ohio 44124 —
Lake University Ireland Cancer Center Mentor Ohio 44060 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Tulsa Cancer Institute Tulsa Oklahoma 74146 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Geisinger Medical Center-Cancer Center Hazleton Hazleton Pennsylvania 18201 —
Geisinger Medical Group State College Pennsylvania 16801 —
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre Pennsylvania 18711 —
Women and Infants Hospital Providence Rhode Island 02905 —
M D Anderson Cancer Center CCOP Research Base Houston Texas 77030 —
M D Anderson Cancer Center Houston Texas 77030 —
PeaceHealth Medical Group PC Bellingham Washington 98226 —
Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton Washington 98310 —
Harrison Medical Center Bremerton Washington 98310 —
Providence Regional Cancer Partnership Everett Washington 98201 —
Skagit Valley Hospital Regional Cancer Care Center Mount Vernon Washington 98273 —
Harrison HealthPartners Hematology and Oncology-Poulsbo Poulsbo Washington 98370 —
Pacific Gynecology Specialists Seattle Washington 98104 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
Group Health Cooperative-Seattle Seattle Washington 98112 —
Swedish Medical Center-First Hill Seattle Washington 98122-4307 —
Northwest Hospital Seattle Washington 98133 —
University of Washington Medical Center Seattle Washington 98195 —
Olympic Medical Cancer Care Center Sequim Washington 98384 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Rockwood Cancer Treatment Center-DHEC-Downtown Spokane Washington 99204 —
MultiCare Tacoma General Hospital Tacoma Washington 98405 —
Saint Joseph Medical Center Tacoma Washington 98405 —
Providence Saint Mary Regional Cancer Center Walla Walla Washington 99362 —
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01196429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2019 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01196429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →